Category: Grants

Global Lupus Community Rallied by Lady Gaga, Selena Gomez, Norm Lewis and a Host of Inspiring Lupus Advocates New York, NY. November 24 – The Lupus Research Alliance (LRA)’s 2020 Virtual Fundraising Event surpassed its...

Medicare Open Enrollment begins on October 15, 2020 and ends on December 7, 2020. During this time, Medicare beneficiaries can compare coverage options like Original Medicare and Medicare Advantage and choose health and drug...

Lady Gaga and Selena Gomez Invite Global Lupus Community New York, NY. November 19 – The Lupus Research Alliance (LRA) is taking the show on-line this year with a preeminent virtual Fundraising Event celebrating extraordinary...

FOR IMMEDIATE RELEASE November 19, 2020- After hiking the Continental Divide for the past five months, Jonathan Maidment completes his third hiking journey and achieves the Triple Crown! Maidment adds this last hike of...

November 10, 2020 Lupus affects individuals differently, from disease symptoms to responses to treatments.  Lupus patients of African ancestry often show significantly greater severity of lupus and respond to lupus drugs differently than lupus...

FOR IMMEDIATE RELEASE November 2, 2020- The Alpha-1 Foundation is proud to announce the establishment of the Alpha-1 Foundation Therapeutic Development Network (TDN). The Alpha-1 TDN is a collaborative group comprised of the top...

November 11, 2020 The Lupus Research Alliance is pleased to share details of the 2021 spending package announced by the U.S. Senate last night with several potential “wins” for lupus research. While not 100%...

“Joe Zuraw has been a friend to the Alpha-1 Community for more than 20 years, he has worked tirelessly on behalf of patients his entire career. This honor could not be a better tribute...

More than 30 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from three clinical studies conducted in part by LRA-affiliate Lupus Therapeutics (LT) through its trials...

COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies...